Real-world of Nintedanib in a Spanish non-IPF progressive pulmonary fibrosis cohort

被引：0
|
作者：
Vicens Zygmunt, Vanesa [1 ]
Bordas-Martinez, Jaume [1 ]
Munoz-Bolano, Miriam [2 ]
Carmezim-Correia, Joao [3 ]
Belen Llanos-Gonzalez, Ana [4 ]
Domingo-Carnice, Adria [5 ]
Rodriguez-Cumplido, Dolores [5 ]
Bermudo-Peloche, Guadalupe [1 ]
Tebe-Cordomi, Cristian [6 ]
Llop-Rius, Roser [5 ]
Molina-Molina, Maria [7 ]
机构：
[1] Univ Hosp Bellvitge, ILD Unit, Barcelona, Spain
[2] Univ Hosp Bellvitge, Barcelona, Spain
[3] Bellvitge Biomed Res Inst IDIBELL, Biostatist Unit UBiDi, Barcelona, Spain
[4] Univ Complex Hosp Canarias, ILD Unit, Santa Cruz De Tenerife, Spain
[5] Univ Hosp Bellvitge, Barcelona, Spain
[6] Bellvitge Biomed Res Inst IDIBELL, Biostat Unit UBiDi, Barcelona, Spain
[7] Univ Hosp Bellvitge, ILD Unit, Barcelona, Spain
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA408
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Multicenter real-world data of antifibrotics in non-IPF progressive pulmonary fibrosis (PPF) patients
    Ocal, Nesrin
    Cilli, Aykut
    Bishop, Nesrin Mogulkoc
    Coskun, Funda
    Ursavas, Ahmet
    Hanta, Ismail
    Ozyurek, Berna Akinci
    Ensarioglu, Kerem
    Erzincan, Alper
    Yuksel, Esra
    Arikan, Beste
    Uzer, Fatih
    Ozdemirel, Tugce Sahin
    Misirci, Salim
    Deniz, Pelin Pinar
    Basyigit, Ilknur
    Kumbasar, Ozlem Ozdemir
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [2] Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study
    Raman, Lavanya
    Stewart, Iain
    Barratt, Shaney L.
    Chua, Felix
    Chaudhuri, Nazia
    Crawshaw, Anjali
    Gibbons, Michael
    Hogben, Charlotte
    Hoyles, Rachel
    Kouranos, Vasilis
    Martinovic, Jennifer
    Mulholland, Sarah
    Myall, Katherine J.
    Naqvi, Marium
    Renzoni, Elisabetta A.
    Saunders, Peter
    Steward, Matthew
    Suresh, Dharmic
    Thillai, Muhunthan
    Wells, Athol U.
    West, Alex
    Mitchell, Jane A.
    George, Peter M.
    ERJ OPEN RESEARCH, 2023, 9 (02)
  • [3] A real-life cohort of antifibrotic-treated non-IPF progressive pulmonary fibrosis patients
    Renner, A.
    Vertanen, E.
    Sutinen, E.
    Ainola, M.
    Myllaerniemi, M.
    Hollmen, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S552 - S552
  • [4] Nintedanib bei progressiver Nicht-IPF-Lungenfibrose – eine SubgruppenanalyseNintedanib in progressive non-IPF pulmonary fibrosis—A subgroup analysis
    Philipp Markart
    Der Pneumologe, 2020, 17 (5): : 350 - 351
  • [5] Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
    Finnerty, James Patrick
    Ponnuswamy, Aravind
    Dutta, Prosjenjit
    Abdelaziz, Ammar
    Kamil, Hafiz
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [6] Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
    James Patrick Finnerty
    Aravind Ponnuswamy
    Prosjenjit Dutta
    Ammar Abdelaziz
    Hafiz Kamil
    BMC Pulmonary Medicine, 21
  • [7] Nintedanib in progressive Non-IPF-Pulmonary Fibrosis - A Subgroup Analysis
    Markart, Philipp
    PNEUMOLOGE, 2020, 17 (05): : 350 - 351
  • [8] Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
    Brunnemer, Eva
    Waelscher, Julia
    Tenenbaum, Svenja
    Hausmanns, Julia
    Schulze, Karen
    Seiter, Marianne
    Heussel, Claus Peter
    Warth, Arne
    Herth, Felix J. F.
    Kreuter, Michael
    RESPIRATION, 2018, 95 (05) : 301 - 309
  • [9] Real-World Safety and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
    Azuma, Arata
    Ogura, Takashi
    Inoue, Yoshikazu
    Kondoh, Yasuhiro
    Homma, Sakae
    Tanaka, Katsumi
    Ochiai, Kaori
    Muraishi, Kenya
    Sugiyama, Yukihiko
    Nukiwa, Toshihiro
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study
    Cameli, Paolo
    Alonzi, Valerio
    d'Alessandro, Miriana
    Bergantini, Laura
    Pordon, Elena
    Guerrieri, Marco
    Refini, Rosa Metella
    Sestini, Piersante
    Bargagli, Elena
    BIOMEDICINES, 2022, 10 (08)
12345